PCSA
Processa Pharmaceuticals, Inc.$2.34+0.05 (+2.19%)Prev Close$2.29·MCap$6.3M·P/E—·Vol24.9K·Yield—
▲
Buys (12M)
41
$206.5K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$206.5K
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Processa Pharmaceuticals, Inc. (PCSA) has been exclusively buying, with 41 insider purchases totaling $206.5K and 0 insider sales totaling $0.00. The most recent insider transaction was by Lin Patrick (officer: Chief Business - Strategy Off), who purchased $4.1K worth of shares on Jul 1, 2026. Processa Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $6.3M.
PCSA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 2,106 | $1.93 | $4.1K | 13,113 |
| Jul 1, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 2,531 | $1.93 | $4.9K | 21,729 |
| Jul 1, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 3,057 | $1.93 | $5.9K | 15,492 |
| Jul 1, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 2,436 | $1.93 | $4.7K | 14,394 |
| Jul 1, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 3,277 | $1.93 | $6.3K | 16,689 |
| Jun 16, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 2,067 | $2.22 | $4.6K | 19,198 |
| Jun 16, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 2,465 | $2.22 | $5.5K | 12,435 |
| Jun 16, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 2,654 | $2.22 | $5.9K | 13,412 |
| Jun 16, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,831 | $2.22 | $4.1K | 11,007 |
| Jun 16, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 2,118 | $2.22 | $4.7K | 11,958 |
| Jun 1, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,829 | $2.57 | $4.7K | 9,840 |
| Jun 1, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 2,292 | $2.57 | $5.9K | 10,758+27% |
| Jun 1, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,582 | $2.57 | $4.1K | 9,176 |
| Jun 1, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,786 | $2.57 | $4.6K | 17,131 |
| Jun 1, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 2,129 | $2.57 | $5.5K | 9,970+27% |
| May 19, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 1,843 | $2.97 | $5.5K | 7,841+31% |
| May 19, 2026 | Bigora Sian | officer: Chief Development Officer | Buy | 1,971 | $2.71 | $5.3K | 7,481+36% |
| May 19, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,545 | $2.97 | $4.6K | 15,345 |
| May 19, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,583 | $2.97 | $4.7K | 8,011 |
| May 19, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,369 | $2.97 | $4.1K | 7,594 |
| May 19, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 1,984 | $2.97 | $5.9K | 8,466+31% |
| May 1, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,706 | $2.69 | $4.6K | 13,813 |
| May 1, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,748 | $2.69 | $4.7K | 6,441+37% |
| May 1, 2026 | Bigora Sian | officer: Chief Development Officer | Buy | 1,986 | $2.69 | $5.3K | 7,496+36% |
| May 1, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,511 | $2.69 | $4.1K | 6,236+32% |
| May 1, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 2,034 | $2.69 | $5.5K | 6,013+51% |
| May 1, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 2,190 | $2.69 | $5.9K | 6,498+51% |
| Apr 17, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 1,984 | $2.97 | $5.9K | 4,308+85% |
| Apr 17, 2026 | Bigora Sian | officer: Chief Development Officer | Buy | 1,799 | $2.97 | $5.3K | 5,510+48% |
| Apr 17, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,583 | $2.97 | $4.7K | 4,693+51% |
| Apr 17, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 1,843 | $2.97 | $5.5K | 5,492+51% |
| Apr 17, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,545 | $2.97 | $4.6K | 12,107 |
| Apr 17, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,369 | $2.97 | $4.1K | 4,725+41% |
| Apr 1, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,810 | $2.54 | $4.6K | 10,562 |
| Apr 1, 2026 | Baluch Khoso | director | Buy | 2,269 | $2.53 | $5.8K | 2,325New Position |
| Apr 1, 2026 | Bigora Sian | officer: Chief Development Officer | Buy | 2,107 | $2.53 | $5.3K | 3,711+131% |
| Apr 1, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,854 | $2.54 | $4.7K | 3,110+148% |
| Apr 1, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,603 | $2.54 | $4.1K | 3,356+91% |
| Apr 1, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 2,324 | $2.53 | $5.9K | 2,324 |
| Apr 1, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 2,136 | $2.53 | $5.4K | 3,649+141% |
| Apr 1, 2026 | Pannu Geraldine | director | Buy | 2,072 | $2.54 | $5.3K | 2,188New Position |
| Apr 1, 2025 | Young David | Pres. Research & Development | Sell | 5,345 | $0.41 | $2.2K | 0 |
| Jan 31, 2025 | Yorke Justin W | Buy | 12,400 | $0.80 | $9.9K0.5% OS | 12,400 | |
| Jan 29, 2025 | Lin Patrick | Chief Business - Strategy Off | Buy | 43,500 | $0.80 | $34.7K1.9% OS | 43,500 |
| Jan 29, 2025 | Ng George K | Chief Executive Officer | Buy | 87,200 | $0.80 | $69.5K3.8% OS | 87,200 |
| Jan 29, 2025 | Young David | Pres. Research & Development | Buy | 124,500 | $0.80 | $99.3K5.5% OS | 205,405+154% |
| Feb 8, 2024 | Young David | Pres. Research & Development | Buy | 21,000 | $2.45 | $51.5K0.9% OS | 79,387+36% |
| Feb 7, 2024 | Young David | Pres. Research & Development | Buy | 20,000 | $2.53 | $50.5K0.9% OS | 58,387+52% |
| Feb 1, 2024 | Lin Patrick | Chief Business - Strategy Off | Buy | 4,000 | $2.38 | $9.5K | 27,478 |
| Jan 31, 2024 | Ng George K | Chief Executive Officer | Buy | 10,000 | $2.70 | $27.0K | 20,000+100% |
Showing 1–50 of 67
1 / 2
PCSA Insider Buying Activity
The following table shows recent insider purchases of Processa Pharmaceuticals, Inc. (PCSA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 2,106 | $1.93 | $4.1K | 13,113 |
| Jul 1, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 2,531 | $1.93 | $4.9K | 21,729 |
| Jul 1, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 3,057 | $1.93 | $5.9K | 15,492 |
| Jul 1, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 2,436 | $1.93 | $4.7K | 14,394 |
| Jul 1, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 3,277 | $1.93 | $6.3K | 16,689 |
| Jun 16, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 2,067 | $2.22 | $4.6K | 19,198 |
| Jun 16, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 2,465 | $2.22 | $5.5K | 12,435 |
| Jun 16, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 2,654 | $2.22 | $5.9K | 13,412 |
| Jun 16, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,831 | $2.22 | $4.1K | 11,007 |
| Jun 16, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 2,118 | $2.22 | $4.7K | 11,958 |
| Jun 1, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,829 | $2.57 | $4.7K | 9,840 |
| Jun 1, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 2,292 | $2.57 | $5.9K | 10,758+27% |
| Jun 1, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,582 | $2.57 | $4.1K | 9,176 |
| Jun 1, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,786 | $2.57 | $4.6K | 17,131 |
| Jun 1, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 2,129 | $2.57 | $5.5K | 9,970+27% |
| May 19, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 1,843 | $2.97 | $5.5K | 7,841+31% |
| May 19, 2026 | Bigora Sian | officer: Chief Development Officer | Buy | 1,971 | $2.71 | $5.3K | 7,481+36% |
| May 19, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,545 | $2.97 | $4.6K | 15,345 |
| May 19, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,583 | $2.97 | $4.7K | 8,011 |
| May 19, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,369 | $2.97 | $4.1K | 7,594 |
| May 19, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 1,984 | $2.97 | $5.9K | 8,466+31% |
| May 1, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,706 | $2.69 | $4.6K | 13,813 |
| May 1, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,748 | $2.69 | $4.7K | 6,441+37% |
| May 1, 2026 | Bigora Sian | officer: Chief Development Officer | Buy | 1,986 | $2.69 | $5.3K | 7,496+36% |
| May 1, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,511 | $2.69 | $4.1K | 6,236+32% |
| May 1, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 2,034 | $2.69 | $5.5K | 6,013+51% |
| May 1, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 2,190 | $2.69 | $5.9K | 6,498+51% |
| Apr 17, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 1,984 | $2.97 | $5.9K | 4,308+85% |
| Apr 17, 2026 | Bigora Sian | officer: Chief Development Officer | Buy | 1,799 | $2.97 | $5.3K | 5,510+48% |
| Apr 17, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,583 | $2.97 | $4.7K | 4,693+51% |
| Apr 17, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 1,843 | $2.97 | $5.5K | 5,492+51% |
| Apr 17, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,545 | $2.97 | $4.6K | 12,107 |
| Apr 17, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,369 | $2.97 | $4.1K | 4,725+41% |
| Apr 1, 2026 | Young David | director, officer: Pres. Research & Development | Buy | 1,810 | $2.54 | $4.6K | 10,562 |
| Apr 1, 2026 | Baluch Khoso | director | Buy | 2,269 | $2.53 | $5.8K | 2,325New Position |
| Apr 1, 2026 | Bigora Sian | officer: Chief Development Officer | Buy | 2,107 | $2.53 | $5.3K | 3,711+131% |
| Apr 1, 2026 | Guy Wendy | officer: Chief Administrative Officer | Buy | 1,854 | $2.54 | $4.7K | 3,110+148% |
| Apr 1, 2026 | Lin Patrick | officer: Chief Business - Strategy Off | Buy | 1,603 | $2.54 | $4.1K | 3,356+91% |
| Apr 1, 2026 | SKIBSTED RUSSELL | officer: Chief Financial Officer | Buy | 2,324 | $2.53 | $5.9K | 2,324 |
| Apr 1, 2026 | Ng George K | director, officer: Chief Executive Officer | Buy | 2,136 | $2.53 | $5.4K | 3,649+141% |
| Apr 1, 2026 | Pannu Geraldine | director | Buy | 2,072 | $2.54 | $5.3K | 2,188New Position |
| Jan 31, 2025 | Yorke Justin W | Buy | 12,400 | $0.80 | $9.9K0.5% OS | 12,400 | |
| Jan 29, 2025 | Lin Patrick | Chief Business - Strategy Off | Buy | 43,500 | $0.80 | $34.7K1.9% OS | 43,500 |
| Jan 29, 2025 | Ng George K | Chief Executive Officer | Buy | 87,200 | $0.80 | $69.5K3.8% OS | 87,200 |
| Jan 29, 2025 | Young David | Pres. Research & Development | Buy | 124,500 | $0.80 | $99.3K5.5% OS | 205,405+154% |
| Feb 8, 2024 | Young David | Pres. Research & Development | Buy | 21,000 | $2.45 | $51.5K0.9% OS | 79,387+36% |
| Feb 7, 2024 | Young David | Pres. Research & Development | Buy | 20,000 | $2.53 | $50.5K0.9% OS | 58,387+52% |
| Feb 1, 2024 | Lin Patrick | Chief Business - Strategy Off | Buy | 4,000 | $2.38 | $9.5K | 27,478 |
| Jan 31, 2024 | Ng George K | Chief Executive Officer | Buy | 10,000 | $2.70 | $27.0K | 20,000+100% |
PCSA Insider Selling Activity
The following table shows recent insider sales of Processa Pharmaceuticals, Inc. (PCSA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | Young David | Pres. Research & Development | Sell | 5,345 | $0.41 | $2.2K | 0 |
PCSA Insiders
Similar Stocks to PCSA
VRTX
Vertex Pharmaceuticals Incorporated
$477.45+0.18%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$661.90+0.88%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$279.67-0.60%
$43.19B
RVMD
Revolution Medicines, Inc.
$184.79-0.09%
$40.34B
MRNA
Moderna, Inc.
$67.55+0.16%
$27.09B
INSM
Insmed Incorporated
$109.58-0.48%
$25.06B
INCY
Incyte Corporation
$114.75-0.11%
$23.32B
UTHR
United Therapeutics Corporation
$530.82+0.79%
$23.22B